Effectiveness of Shockwave Treatment Combined With Eccentric Training For Patellar Tendinopathy: A Double-Blinded Randomized Study
Effectiveness of Shockwave Treatment Combined With Eccentric Training For Patellar Tendinopathy: A Double-Blinded Randomized Study
Karin M. Thijs, MD,* Johannes Zwerver, MD, PhD,† Frank J. G. Backx, MD, PhD,*
Victor Steeneken, PT, MSc,‡ Stephan Rayer, PT,§ Petra Groenenboom, MD,¶ and
Maarten H. Moen, MD PhD*k**
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Thijs et al Clin J Sport Med Volume 27, Number 2, March 2017
determine the effectiveness of a combined treatment of surgery (on the anterior cruciate ligament or the patellar
eccentric training and ESWT compared with eccentric tendon), (4) a local (corticosteroid) injection of the knee in the
training and sham shockwave (placebo) in participants with past month, (5) contraindications for ESWT treatment (eg,
PT during a 24-week follow-up. We hypothesized that pregnancy, malignancy, coagulopathy), or (6) participants
participants treated with this combined approach of eccentric who received ESWT before (ie, these participants are not
training and ESWT will improve significantly more in blinded to the ESWT treatment).
Downloaded from http://journals.lww.com/cjsportsmed by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC
Shockwave Treatment
The focused ESWT and sham-shockwave treatments
METHODS were provided by two independent physical therapists (at 2
different locations in the Netherlands). Both physical thera-
Study Design pists are qualified and experienced in application of ESWT.
The PATELLASS study is a multicenter randomized The device was placed on the most painful spot with the knee
and placebo-controlled trial conducted at the sports medicine extended. Extracorporeal shockwave therapy was applied in 3
departments of a university hospital [University Medical sessions at 1-week intervals with a Piezoelectric ESWT
Center Utrecht (UMCU), Utrecht, the Netherlands] and device (Swiss PiezoClast; Electro Medical Systems, Nyon,
a general hospital [Medical Center Haaglanden (MCH), Switzerland) using 1000 pulses in a frequency of 4 Hz and an
Leidschendam, the Netherlands]. Participants were random- energy density level of 0.2 mJ/mm2. The energy density was
ized to either eccentric exercises in combination with ESWT gradually increased during the session. There is still consider-
(ESWT group) or eccentric exercises in combination with able controversy in ESWT protocols with respect to the num-
sham-shockwave therapy (placebo group). Participants and ber of sessions and dosage. Manufacturers of comparable
outcome assessors were blinded to the designated intervention low–medium dose energy devices consistently recommend
at all time during follow-up at 6, 12, and 24 weeks. The between 3 and 5 sessions.4 Current treatment protocol was
physical therapists providing the shockwave treatment were chosen because of the usability and tolerance in the study of
not blinded to the intervention because they had to adjust Peers.9
the shockwave device to “true” or “sham” treatment. These The sham-shockwave treatment procedure for the
physical therapists were not involved in the follow-up of the control group was nearly the same as the ESWT treatment
participants. and was administered with the same device, in 3 sessions at
1-week interval, using 1000 pulses in a frequency of 4 Hz
Participants and an energy level 1.9,10 Transmission gel was applied
Study participants were recruited from general practi- between the focusing pad and the skin of the participants,
tioners, sports medicine, and physical therapy practices. A but not between the applicator and focusing pad. In this way,
digital letter was sent to potential referring physicians and shockwaves were hardly conducted and had a maximum
physical therapists to inform them about the study. They were energy density level of 0.03 mJ/mm2.10 The participants
asked to refer eligible participants to the sports medicine were told that the treatment could be painful but that there
departments of the UMCU or MCH. All participants who is an interindividual variation in pain perception. By press-
matched the inclusion and exclusion criteria and were willing ing the applicator to the painful spot, the participants expe-
to participate in the study were included. rienced some pain. They also heard the repetitive pulses
Inclusion criteria were the presence of PT in generated by the shockwave device, but were unaware of
participants active in sports at least once a week and an age the dosage.
between 18 and 40 years. Patellar tendinopathy was diag-
nosed by sports medicine physicians based on the following Eccentric Training
clinical findings: (1) history of knee pain located in the All participants were instructed by trained physical
patellar tendon or its patellar insertion related to activity, (2) therapists on how to perform the eccentric exercises on
recognizable palpation tenderness of the patella tendon or its a decline board of approximately 25 degrees at home. Each
insertion on the patella, (3) symptoms present for over 8 training session had to be completed twice daily, with 3 sets
weeks, and (4) the VISA-P score less than 80 at baseline. of 15 repetitions being performed at each session, during 12
During loading, the pain had to remain isolated to the weeks.11 The exercises were performed without warming up.
circumscript part of the tendon or tendon bone junction and The downward (eccentric) component was performed with
not spread to whole patellar region (to distinguish between PT the affected leg, and the upward (concentric) component
and patellofemoral pain). In case of bilateral complaints, the was performed with both legs. Participants were instructed
most painful knee was included. to complete the exercises with the trunk upright. They were
Exclusion criteria were (1) acute knee or acute patellar advised not to exceed a pain level of 4 on a numeric rating
tendon injury, chronic inflammatory joint diseases [(rheuma- scale (NRS) for pain (0 = no pain to 10 = worst pain ever)
toid) arthritis] or signs or symptoms of other (co-) existing during the eccentric training sessions. When pain decreased to
knee pathologies, (2) using immunosuppressive or cortico- NRS ,4, the participants were instructed to add load in
steroid medication in the last 6 months, (3) previous knee a backpack. If pain increased to .5, the participants were
90 | www.cjsportmed.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Clin J Sport Med Volume 27, Number 2, March 2017 A Double-Blinded Randomized Study
BMI 23.9 6 3.5 (19.9-32.3) 23.4 6 2.4 (18.1-27.0) 0.492 23.6 6 (18.1-32.3) 24.5 6 3.8 (20.3-32.2)
Hours of sports per week 4.5 6 3.8 (0-16) 4.1 6 2.7 (0-8) 0.673 4.3 6 3.2 (0-16) 4.7 6 4.2 (0-16)
Mean VISA-P 6 SD 54.5 6 15.4 (21-78) 58.9 6 14.6 (20-80) 0.298 57.1 6 14.9 (20-80) 57.7 6 13.7 (38-80)
ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 10/25/2023
Duration of symptoms in weeks 65.1 6 72.7 (12-312) 99.4 6 126.3 (12-500) 0.260 84.9 6 107.4 (12-500) 91.5 6 108.6 (12-312)
Primary sport 7 Running 8 Cycling/spinning
6 Soccer 6 Soccer
1 Athletics 4 Running
1 Basketball 4 Tennis/squash
1 Badminton 2 Athletics
1 Fitness 1 Badminton
1 Field hockey 1 Field hockey
1 Korfball 1 Skating
1 Triathlon 1 Volleyball
1 Gymnastics 1 Kickboxing
1 Aerobics 1 Unknown
BMI, body mass index.
instructed to perform the exercise with less weight or tempo- points.14 With a power of 80% and an alpha of 5%, 28 ath-
rarily adjust the amount of repetitions. letes per group were needed to detect a clinically relevant
Furthermore, they were allowed to perform sport at difference.
a pain level not exceeding NRS 4. No restrictions were given The allocation to treatment took place after baseline
for adjuvant physical therapy treatment, but it was not assessment by the sports medicine physician. Randomization
encouraged. Adjuvant treatment was registered at follow-up. (simple randomization procedure) was performed using
sealed identical nonopaque envelopes containing cards with
Outcome “A” or “B” on it. An independent nurse at each of the loca-
The primary outcome measure was the validated Dutch tions was responsible for preparation and execution of this
translation of the VISA-P questionnaire, which quantifies the procedure. Slightly more envelopes per location were pre-
pain and activity level and is specifically designed for pared as was calculated in the power analysis, because we
evaluating outcome in PT.12,13 The VISA-P score ranges from intended to include more participants than strictly needed.
0 to 100 (0 = no activity/maximum pain and 100 = maximum After opening the envelope, the card with “A” or “B” on it
activity/no pain). was handed over to the physical therapist on that location.
Secondary outcome measures were pain scores during The 2 care providers (physical therapists) providing the
functional knee loading tests, as rated verbally by a NRS for (sham-) shockwave treatment were the only ones who knew
pain on a scale of 0 to 10 (0 = no pain and 10 = worst pain the representation of “A” or “B.” Allocation information was
ever). The pain was scored during 10 single-leg decline withheld from the participants and the outcome assessors for
squats, during 3 single-leg jumps, and during 3 single-leg the duration of the data collection (24 weeks).
maximal vertical jumps of the affected leg.10 Satisfaction
was rated on a 6-point Likert scale at follow-up assessments Statistical Methods
(1: completely recovered; 2: much better; 3: a little better; 4: Baseline characteristics and outcome measures at
unchanged; 5: worse; and 6: much worse). follow-up were tabulated using descriptive statistics (mean
Follow-up measurements were performed at 6, 12, and and SDs, numbers, and percentages). Independent sample
24 weeks after the start with the ESWT or sham-shockwave t-tests were used to assess the difference between baseline
treatment. Side effects, adverse reactions, and the compliance characteristics and the number of exercise sessions between
to eccentric exercises were recorded. the groups. Differences between categorical data were
assessed by the x2 test. Repeated-measures analysis was used
Sample Size, Randomization, and Blinding to assess the difference on the primary and secondary out-
The sample size was estimated based on the difference come variables between the groups over time. Analyses were
in VISA-P scores between symptomatic and asymptomatic performed following the intention-to-treat principle (both
participants, with a clinically relevant difference in VISA-P mean value substitution and last observation carried forward
scores of 15 points. Baseline scores of 64 points were were performed; results for mean value substitution were
expected in symptomatic participants with an SD of 19 given). Two-sided P values of ,0.05 were considered
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. www.cjsportmed.com | 91
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Thijs et al Clin J Sport Med Volume 27, Number 2, March 2017
significant. All statistical analyses were performed using IBM scores were 55.9 6 15.4 for the group that completed the
SPSS Statistical software package version 20 (SPSS Inc, study protocol and 57.7 6 13.7 for the lost-to-follow-up
Chicago, Illinois). group (P = 0.871).
The mean number of eccentric exercise sessions per
Ethical Considerations week (maximum of 14) for the ESWT and placebo group was
The Medical Ethical Committee of the UMCU and 10.1 6 4.5 and 9.8 6 3.8 sessions at 6 weeks (P = 0.753) and
Downloaded from http://journals.lww.com/cjsportsmed by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC
MCH approved the study protocol before its start (protocol 8.7 6 4.2 and 6.1 6 5.2 sessions at 12 weeks (P = 0.065),
number 10/202/C). All participants were fully informed about respectively.
the nature of the trial and its rationale. All participants Because of the low number of reported cointerventions
ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 10/25/2023
provided written informed consent. in both groups, the possible influence of cointerventions on
the primary outcome (VISA-P) was not further examined.
92 | www.cjsportmed.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Clin J Sport Med Volume 27, Number 2, March 2017 A Double-Blinded Randomized Study
Downloaded from http://journals.lww.com/cjsportsmed by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC
ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 10/25/2023
Secondary Outcome Measure The Likert scores for patient satisfaction are presented in
The mean NRS scores at baseline and follow-up are Table 3, showing no significant differences between the 2 groups
presented in Table 2. Both groups significantly improved over at 6, 12, and 24 weeks (P = 0.127, P = 0.755, and P = 0.928
the study period. No significant differences were found respectively). Sixty-seven percent in ESWT and 69% in the
between the ESWT and the sham-shockwave group (except sham-shockwave group reported good outcomes after 24 weeks
for pain during 3 maximal vertical jumps at 6 weeks, in favor (much better or completely resolved). No complications were
of the sham-shockwave group). reported after ESWT or sham-shockwave treatment.
TABLE 2. Primary and Secondary Outcome Measures at Baseline, 6, 12, and 24 Weeks in ESWT and Sham-Shockwave Group
(Placebo)
ESWT (n = 22) Sham Shockwave (n = 30)
Baseline, Week 6, Week 12, Week 24, Baseline, Week 6, Week 12, Week 24,
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
VISA-P score (0-100) 54.5 (15.4) 61.4 (19.2) 65.7 (17.3) 70.9 (17.7) 58.9 (14.6) 67.3 (17.8) 71.5 (21.7) 78.2 (15.8)
Pain during 10 decline 4.1 (2.4) 3.3 (2.4) 2.0 (1.5) 1.8 (1.8) 4.7 (2.5) 3.1 (2.7) 2.9 (2.5) 2.2 (2.3)
squats (0-10)
Pain during 3 single- 3.3 (2.6) 3.5 (2.9) 2.4 (1.7) 1.8 (1.8) 3.2 (2.7) 2.3 (1.8) 2.3 (2.2) 1.9 (1.9)
leg jumps (0-10)
Pain during 3 maximal 2.8 (2.9) 3.3 (2.3) 2.1 (1.7) 1.6 (1.9) 3.8 (2.4) 2.0 (2.0) 2.2 (2.0) 1.5 (1.9)
vertical jumps (0-10)
Between-Group Between-Group Between-Group
Difference Difference Difference
(95% CI), Week 6 (95% CI), Week 12 (95% CI), Week 24
VISA-P score (0-100) 21.4 (29.0 to 6.2) 23.0 (12.3 to 6.3) 24.8 (212.7 to 3.0)
Pain during 10 decline squats (0-10) 0.8 (20.6 to 2.2) 20.4 (21.5 to 0.8) 0.4 (21.0 to 1.9)
Pain during 3 single-leg jumps (0-10) 1.0 (20.3 to 2.4) 20.1 (21.4 to 1.2) 20.2 (21.6 to 1.2)
Pain during 3 maximal vertical jumps 2.2 (0.9 to 3.4)* 0.6 (20.6 to 1.8) 1.2 (20.2 to 2.5)
(0-10)
*P , 0.05.
CI, confidence interval.
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. www.cjsportmed.com | 93
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Thijs et al Clin J Sport Med Volume 27, Number 2, March 2017
94 | www.cjsportmed.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Clin J Sport Med Volume 27, Number 2, March 2017 A Double-Blinded Randomized Study
However, this difference in lost to follow-up percentage was with eccentric exercises. The primary (VISA-P) and second-
not significant between the groups and no significant differ- ary outcome measures (pain scores during functional tests and
ences were found for baseline characteristics and VISA-P Likert scores) did not differ significantly between the groups
scores between participants lost to follow-up and participants during the 24-week follow-up period. Because of low power
who completed the full 24-week follow-up period, irrespec- of the study caused by a high percentage of participants lost to
tively of the treatment group. This makes attrition bias less follow-up, particularly in the ESWT group, these conclusions
Downloaded from http://journals.lww.com/cjsportsmed by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC
This may have lead to a possible different interaction with the REFERENCES
participants or a possible influence on the administered 1. Cook JL, Khan KM, Harcourt PR, et al. A cross sectional study of 100
athletes with jumper’s knee managed conservatively and surgically. The
treatment and consequently the outcomes. Analyses of the Victorian Institute of Sport Tendon Study Group. Br J Sports Med. 1997;
primary outcome measure VISA-P between the 2 different 31:332–336.
locations did however not show differences after 12 and 24 2. Gaida JE, Cook J. Treatment options for patellar tendinopathy: critical
weeks of follow-up (with similar baseline VISA-P scores of review. Curr Sports Med Rep. 2011;10:255–270.
56.7 6 13.6 and 57.6 6 17.0 points). We therefore do not 3. Visnes H, Bahr R. The evolution of eccentric training as treatment for
patellar tendinopathy (jumper’s knee): a critical review of exercise pro-
expect biased results by the fact that the interventions were grammes. Br J Sports Med. 2007;41:217–223.
performed by 2 (unblinded) caregivers. 4. Chung B, Wiley JP. Extracorporeal shockwave therapy: a review. Sports
The power analysis before the start of the study Med. 2002;32:851–865.
revealed that 56 patients in total were needed to detect 5. van der Worp H, van den Akker-Scheek I, van Schie H, et al. ESWT for
tendinopathy: technology and clinical implications. Knee Surg Sports
a clinically relevant difference in the VISA-P score of 15 Traumatol Arthrosc. 2013;21:1451–1458.
points. Because of a limited inclusion period, we included 6. Notarnicola A, Moretti B. The biological effects of extracorporeal shock
a slightly less number of 52 participants, which is still a high wave therapy (eswt) on tendon tissue. Muscles Ligaments Tendons J.
number for PT study. For this reason, the chance of a type II 2012;2:33–37.
error slightly increased. A recently published study of 7. van Leeuwen MT, Zwerver J, van den Akker-Scheek I. Extracorporeal
shockwave therapy for patellar tendinopathy: a review of the literature.
Hernandez-Sanchez et al26 shows that a minimal clinically Br J Sports Med. 2009;43:163–168.
important difference for the VISA-P score among athletes 8. Rompe JD, Furia J, Maffulli N. Eccentric loading versus eccentric
with PT is 13 points. This is close to the clinical relevant loading plus shock-wave treatment for midportion achilles tendin-
change of 15 points that we defined. The VISA-P SD in opathy: a randomized controlled trial. Am J Sports Med. 2009;37:
463–470.
our homogenous group of 52 athletes was however lower 9. Peers KH. Extracorporeal Shock Wave Therapy in Chronic Achilles and
(SD 14.9) than expected a priori (SD 19). A poststudy power Patellar Tendinopathy [Thesis]. KU Leuven, 2003. ISBN 9058673049.
analysis based on the lower SD shows that with a power of 10. Zwerver J, Hartgens F, Verhagen E, et al. No effect of extracorporeal
80% and an alpha of 5%, 22 athletes per group would have shockwave therapy on patellar tendinopathy in jumping athletes during
been sufficient to detect a clinically relevant difference in the competitive season: a randomized clinical trial. Am J Sports Med.
2011;39:1191–1199.
VISA-P scores. This retrospectively corresponds to the 11. Visnes H, Hoksrud A, Cook J, et al. No effect of eccentric training on
amount of participants included in this study, but is not jumper’s knee in volleyball players during the competitive season: a ran-
enough to correct for the amount of lost to follow-up. domized clinical trial. Clin J Sport Med. 2005;15:227–234.
A complete case analysis of the primary outcome, 12. Zwerver J, Kramer T, van den Akker-Scheek I. Validity and reliability of
the Dutch translation of the VISA-P questionnaire for patellar tendinop-
excluding the lost-to-follow-up participants from both groups, athy. BMC Musculoskelet Disord. 2009;10:102.
as well as an analysis with imputation of the missing data 13. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an Index of
[according to the intention-to-treat principle (mean value severity of symptoms in patients with jumper’s knee (patellar tendinosis).
substitution and last value carried forward)], did not alter the Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;
outcome of the study. The higher number of participants lost 1:22–28.
14. Lian OB, Engebretsen L, Bahr R. Prevalence of jumper’s knee among
to follow-up in the ESWT group could perhaps be explained elite athletes from different sports: a cross-sectional study. Am J Sports
by the too intense treatment combination. But, as stated Med. 2005;33:561–567.
before, with the exact same treatment protocol as Peers,9 in 15. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology
their study only 4% of the participants were lost to follow-up. model to explain the clinical presentation of load-induced tendinopathy.
Br J Sports Med. 2009;43:409–416.
In the other study on tendinopathy (Achilles) in which eccen- 16. Mani-Babu S, Morrissey D, Waugh C, et al. The effectiveness of extra-
tric training was combined with ESWT, the lost to follow-up corporeal shock wave therapy in lower limb tendinopathy: a systematic
percentage was 12%. The reasons for withdrawal from the review. Am J Sports Med. 2014;43:752–761.
study are not sufficient enough to explain the high percentage. 17. Taunton KM, Taunton JE, Khan KM. Treatment of patellar tendin-
Therefore, it remains largely unknown why our randomized opathy with extracorporeal shock wave therapy. B C Med J. 2003;45:
500–507.
double-blinded study suffered from a high percentage lost to 18. Wang CJ, Ko JY, Chan YS, et al. Extracorporeal shockwave for chronic
follow-up and therefore an increased risk of a type II error. patellar tendinopathy. Am J Sports Med. 2007;35:972–978.
19. Zwerver J, Dekker F, Pepping GJ. Patient guided Piezo-electric
Extracorporeal Shockwave Therapy as treatment for chronic severe
CONCLUSIONS patellar tendinopathy: a pilot study. J Back Musculoskelet Rehabil.
2010;23:111–115.
There is no additional effect of ESWT over sham 20. Furia JP, Rompe JD, Cacchio A, et al. A single application of low-energy
shockwave (placebo) in participants with chronic PT treated radial extracorporeal shock wave therapy is effective for the management
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. www.cjsportmed.com | 95
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Thijs et al Clin J Sport Med Volume 27, Number 2, March 2017
of chronic patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 24. Frohm A, Saartok T, Halvorsen K, et al. Eccentric treatment for patellar
2013;21:346–350. tendinopathy: a prospective randomised short-term pilot study of two
21. Vulpiani MC, Vetrano M, Savoia V, et al. Jumper’s knee treatment with rehabilitation protocols. Br J Sports Med. 2007;41:e7.
extracorporeal shock wave therapy: a long-term follow-up observational 25. Young MA, Cook JL, Purdam CR, et al. Eccentric decline squat protocol
study. J Sports Med Phys Fitness. 2007;47:323–328. offers superior results at 12 months compared with traditional eccentric
22. Lorenzen J, Kramer R, Vogt PM, et al. Systematic review about eccentric protocol for patellar tendinopathy in volleyball players. Br J Sports Med.
training in chronic patella tendinopathy. Sportverletz Sportschaden. 2005;39:102–105.
Downloaded from http://journals.lww.com/cjsportsmed by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC
96 | www.cjsportmed.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright Ó 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.